Vanda Pharmaceuticals (VNDA) Non-Current Deffered Revenue (2010 - 2014)
Vanda Pharmaceuticals (VNDA) reported Non-Current Deffered Revenue of $36.24 million for Q3 2014, down 48.4% from $70.24 million a year earlier and down 17.6% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Non-Current Deffered Revenue (2010 - 2014) Analysis & Trends
At the end of FY2013, Vanda Pharmaceuticals posted Non-Current Deffered Revenue of $63.49 million, down 29.7% from FY2012.
- Non-Current Deffered Revenue has declined for three consecutive years, with a three-year compound annual growth rate of -23.9% (FY2010 to FY2013).
- By year, Non-Current Deffered Revenue came in at $90.28 million in FY2012 (-22.9%), $117.06 million in FY2011 (-18.6%) and $143.85 million in FY2010.
- The Q3 2014 figure ranks as the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2010.
- Year over year, Non-Current Deffered Revenue has now declined in each of the last ten quarters, with an average decline of 32.5% over the last eight quarters.
- Across the past five years, year-over-year decline in Non-Current Deffered Revenue ran from 18.6% in Q4 2011 to 48.4% in Q3 2014.
- Per Business Quant data, the three quarters before Q3 2014 came in at $44 million (Q2 2014), $51.76 million (Q1 2014) and $63.49 million (Q4 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Vanda Pharmaceuticals | 279.91 Mn | -650.03 Mn | 46.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 36.24 Mn |
| Jun 30, 2014 | 44.00 Mn |
| Mar 31, 2014 | 51.76 Mn |
| Dec 31, 2013 | 63.49 Mn |
| Sep 30, 2013 | 70.24 Mn |
| Jun 30, 2013 | 76.99 Mn |
| Mar 31, 2013 | 83.67 Mn |
| Dec 31, 2012 | 90.28 Mn |
| Sep 30, 2012 | 97.03 Mn |
| Jun 30, 2012 | 103.78 Mn |
| Mar 31, 2012 | 110.46 Mn |
| Dec 31, 2011 | 117.06 Mn |
| Sep 30, 2011 | 123.82 Mn |
| Jun 30, 2011 | 130.57 Mn |
| Dec 31, 2010 | 143.85 Mn |
API Access
Vanda Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();